Observatory · observe first
Gilead Sciences
GILD · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
0.476%
12M weight contribution
-0.130 pp
3M weight contribution
+0.187 pp
12M price return
-10.8%
Share of matched S&P 500 members
Monthly observations through Mar 2019
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Mar 2019 | $82.9bn | 0.476% | -0.130 pp | -10.8% | Yes |
| Feb 2019 | $82.9bn | 0.481% | -0.137 pp | -14.8% | Yes |
| Jan 2019 | $90.6bn | 0.299% | -0.326 pp | -13.8% | No |
| Dec 2018 | $80.9bn | 0.289% | -0.335 pp | -23.0% | No |
| Nov 2018 | $93.1bn | 0.309% | -0.315 pp | -12.2% | No |
| Oct 2018 | $88.4bn | 0.300% | -0.325 pp | -16.8% | No |
| Sep 2018 | $100.1bn | 0.319% | -0.305 pp | -5.7% | No |
| Aug 2018 | $98.2bn | 0.317% | -0.307 pp | -8.3% | No |
| Jul 2018 | $101.2bn | 0.590% | -0.034 pp | -5.7% | Yes |
| Jun 2018 | $92.1bn | 0.559% | -0.066 pp | -14.2% | No |
| May 2018 | $87.6bn | 0.532% | -0.093 pp | -19.0% | No |
| Apr 2018 | $94.6bn | 0.581% | -0.043 pp | -13.2% | No |
| Mar 2018 | $98.8bn | 0.606% | -0.018 pp | -9.4% | No |
| Feb 2018 | $103.1bn | 0.618% | -0.006 pp | -6.1% | No |
| Jan 2018 | $109.5bn | 0.624% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.